Thibaut du Fayet
Chief Executive Officer en PHAXIAM THERAPEUTICS S.A. .
Perfil
Thibaut du Fayet is currently the Chief Executive Officer at PHAXIAM Therapeutics SA since 2023.
Previously, he worked as the Deputy Chief Executive Officer at Pherecydes Pharma SA in 2022, Director-Marketing & Strategy at bioMérieux SA, Director at Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd., and Vice President-Business Development & Marketing at Transgene SA from 2008 to 2013.
He also worked as the Head-Marketing at Stallergenes SA from 2007 to 2008.
Mr. du Fayet holds a graduate degree from Brandeis University and an MBA from ESSEC Business School, which he received in 1992.
Cargos activos de Thibaut du Fayet
Empresas | Cargo | Inicio |
---|---|---|
PHAXIAM THERAPEUTICS S.A. | Chief Executive Officer | 23/06/2023 |
Antiguos cargos conocidos de Thibaut du Fayet.
Empresas | Cargo | Fin |
---|---|---|
STALLERGENES | Sales & Marketing | 01/01/2008 |
BIOMÉRIEUX | Sales & Marketing | - |
PHERECYDES PHARMA | Chief Executive Officer | - |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Director/Board Member | - |
TRANSGENE | Corporate Officer/Principal | - |
Formación de Thibaut du Fayet.
Brandeis University | Graduate Degree |
ESSEC Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
PHAXIAM THERAPEUTICS S.A. | Health Technology |
Empresas privadas | 3 |
---|---|
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
- Bolsa de valores
- Insiders
- Thibaut du Fayet